Expression of laminin α1, α2, α4, and α5 chains, fibronectin, and tenascin-C in skeletal muscle of dystrophic 129ReJ dy/dy mice

Experimental Cell Research

Volumn 246, Issue 1, 1999, Pages 165-182

  Ringelmann, Birgit ^a   Röder, Christine ^a   Hallmann, Rupert ^a   Maley, Moira ^b   Davies, Marilyn ^b   Grounds, Miranda ^b   Sorokin, Lydia ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; INTERCELLULAR ADHESION MOLECULE 1; LAMININ; LAMININ ALPHA1; LAMININ ALPHA2; LAMININ ALPHA4; LAMININ ALPHA5; MEMBRANE PROTEIN; MEROSIN; PROTEIN SUBUNIT; TENASCIN; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; ALPHA4 INTEGRIN; ANTIBODY; LEUKOCYTE ANTIGEN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; BASEMENT MEMBRANE; CONTROLLED STUDY; DIAGNOSTIC VALUE; MOUSE; MUSCLE DEVELOPMENT; MUSCULAR DYSTROPHY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; ANIMAL; ANIMAL MUSCULAR DYSTROPHY; BIOSYNTHESIS; DISEASE MODEL; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETICS; HEART MUSCLE; LIMB; LUNG; METABOLISM; NORTHERN BLOTTING; ONSET AGE; PRENATAL DEVELOPMENT; SMOOTH MUSCLE;

ANIMALIA;

AGE OF ONSET; ANIMALS; ANTIBODIES; ANTIGENS, CD; BLOTTING, NORTHERN; DISEASE MODELS, ANIMAL; EXTREMITIES; FIBRONECTINS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; INTEGRIN ALPHA4; INTERCELLULAR ADHESION MOLECULE-1; LAMININ; LUNG; MICE; MUSCLE, SKELETAL; MUSCLE, SMOOTH; MUSCULAR DYSTROPHY, ANIMAL; MYOCARDIUM; TENASCIN; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0033540112     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4244     Document Type: Article

References (65)

1. Arahata K., Ishii H., Hayashi Y. K. Congenital muscular dystrophies. Curr. Opin. Neurol. 8:1995;385-390.
2. Delwel G. O., Sonnenberg A. Laminin isoforms and their integrin receptors. Adhesion Receptors as Therapeutic Targets. 1996;CRC Press, London.
3. Miner J. H., Lewis R. M., Sanes J. R. Molecular cloning of a novel laminin chain, alpha 5, and widespread expression in adult mouse tissues. J. Biol. Chem. 270:1995;28523-28526.
4. Iivanainen A., Sainio K., Sariola H., Tryggvason K. Primary structure and expression of a novel human laminin alpha 4 chain. FEBS Lett. 365:1995;183-188.
5. Sunada Y., Bernier S. M., Kozak C. A., Yamada Y., Campbell K. P. Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin M chain gene to dy locus. J. Biol. Chem. 269:1994;13729-13732.
6. Xu H., Christmas P., Wu X. R., Wewer U. M., Engvall E. Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse. Proc. Natl. Acad. Sci. USA. 91:1994;5572-5576.
7. Allamand V., Sunada Y., Salih M. A., Straub V., Ozo C. O., Al-Turaiki M. H., Akbar M., Kolo T., Colognato H., Zhang X. Mild congenital muscular dystrophy in two patients with an internally deleted laminin alpha2-chain. Hum. Mol. Genet. 6:1997;747-752.
8. Kuhl U., Ocalan M., Timpl R., von der Mark K. Role of laminin and fibronectin in selecting myogenic versus fibrogenic cells from skeletal muscle cellsin vitro. Dev. Biol. 117:1986;628-635.
9. Ocalan M., Goodman S. L., Kuhl U., Hauschka S. D., von der Mark K. Laminin alters cell shape and stimulates motility and proliferation of murine skeletal myoblasts. Dev. Biol. 125:1988;158-167.
10. Goodman S. L., Risse G., von der Mark K. The E8 fragment of laminin promotes the locomotion of myoblasts over extracellular matrix. J. Cell Biol. 109:1989;799-809.
11. Schuler F., Sorokin L. M. Expression of laminin isoforms in mouse myogenic cells in vitro and in vivo. J. Cell Sci. 108:1995;3795-3805.
12. Ehrig K., Leivo I., Argraves W. S., Ruoslahti E., Engvall E. Merosin: A tissue-specific basement membrane protein is a laminin-like protein. Proc. Natl. Acad. Sci. USA. 87:1990;3264-3268.
13. Paulsson M., Saladin K. Mouse heart laminin. Purification of the native protein and structural comparison with Engelbreth-Holm-Swarm tumour laminin. J. Biol. Chem. 264:1989;18726-18732.
14. Grounds M. D., McGeachie J. K., Davies M. J., Sorokin L. M., Maley M. A. L. The expression of extracellular matrix during adult skeletal muscle regeneration: How the basement membrane, interstitium and myogenic cells collaborate. Basic Appl. Myol. 8:1998;129-142.
15. Michelson A. M., Russel E. S., Harman P. J. Dystrophia muscularis: a hereditary primary myopathy in the house mouse. Proc. Natl. Acad. Sci. USA. 41:1955;1079-1084.
16. Miyagoe Y., Hanaoka K., Nonaka I., Hayasaka M., Nabeshima Y., Arahata K., Nabeshima Y., Takeda S. Laminin alpha 2 chain-null mutant mice by targeted disruption of the LamA2 gene: A new model of merosin (laminin-2)-deficient congenital muscular dystrophy. FEBS Lett. 415:1997;33-39.
17. Rugh R. The Mouse: Its Reproduction and Development. 1968;Burgess, Minneapolis.
18. Christ B., Jacob M., Jacob H. J., Brand B., Wachtler F. Somites and Developing Embryos. 1986;Plenum, New York.
19. Vachon P. H., Loechel F., Xu H., Wewer U. M., Engvall E. Merosin and laminin in myogenesis: Specific requirement for merosin in myotube stability and survival. J Cell Biol. 134:1996;1483-1497.
20. Sewry C. A., Philpot J., Sorokin L. M., Wilson L. A., Naom I., Goodwin F., D'Alessandro M., Dubowitz V., Muntoni F. Diagnosis of merosin (laminin-2) deficient congenital muscular dystrophy by skin biopsy. Lancet. 347:1996;582-584.
21. Chang A. C., Wadsworth S., Coligan J. E. Expression of merosin in the thymus and its interaction with thymocytes. J. Immunol. 151:1993;1789-1801.
22. Virtanen I., Laitinen L., Korhonen M. Differential expression of laminin polypeptides in developing and adult human kidney. J. Histochem. Cytochem. 43:1995;621-628.
23. Leivo I., Engvall E. Merosin, a protein specific for basement membranes of Schwann cells, striated muscle, and trophoblast, is exressed late in nerve and muscle development. Proc. Natl. Acad. Sci. USA. 85:1988;1544-1548.
24. Hayashi Y. K., Engvall E., Arikawa-Hirasawa E., Goto K., Koga R., Nonaka I., Sugita H., Arahata K. Abnormal localization of laminin subunits in muscular dystrophies. J. Neurol. Sci. 119:1993;53-64.
25. Sewry C. A., Chevallay M., Tome F. M. Expression of laminin subunits in human fetal skeletal muscle. Histochem. J. 27:1995;497-504.
26. Sewry C. A., Philpot J., Mahony D., Wilson L. A., Muntoni F., Dubowitz V. Expression of laminin subunits in congenital muscular dystrophy. Neuromuscul. Disord. 5:1995;307-316.
27. Tiger C., Champliaud M., Pedrosa-Domellof F., Thornell L., Ekblom P., Gullberg D. Presence of laminin alpha 5 chain and lack of laminin alpha 1 chain during human muscle development and in muscular dystrophies. J. Biol. Chem. 272:1997;28590-28595.
28. Frieser M., Nöckel H., Pausch F., Röder C., Hahn A., Deutzmann R., Sorokin L. M. Cloning of the mouse laminin alpha 4 gene: expression in a subset of endothelium. Eur. J. Biochem. 246:1997;727-735.
29. Sorokin L. M., Frieser M., Pausch F., Kröger S., Ohage E., Deutzmann R. Developmental regulation of laminin alpha 5 implicates a role in epithelial and endothelial cell maturation. Dev. Biol. 189:1997;285-300.
30. Chiquet-Ehrismann R., Mackie E. J., Pearson C. A., Sakakura T. Tenascin: An extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell. 47:1986;131-139.
31. Mackie E. J., Halfter W., Liverani D. Induction of tenascin in healing wounds. J. Cell Biol. 107:1988;2757-2767.
32. Irintchev A., Salvini T. F., Faissner A., Wernig A. Differential expression of tenascin after denervation, damage or paralysis of mouse soleus muscle. J. Neurocytol. 22:1993;955-965.
33. Miyake K., Medina K., Ishihara K., Kimoto M., Auerbach R., Kincade P. W. A VCAM-like adhesion molecule on murine bone marrow stromal cells mediates binding of lymphocyte precursors in culture. J. Cell Biol. 114:1991;557-565.
34. Kunkel E. J., Jung U., Bullard D. C., Norman K. E., Wolitzky B. A., Vestweber D., Beaudet A. L., Ley K. Absence of trauma-induced leukocyte rolling in mice deficient in both P- selection and intercellular adhesion molecule 1. J. Exp. Med. 183:1996;57-65.
35. Mayer U., Pöschl E., Nischt R., Specks U., Pan T.-C., Chu M.-L., Timpl R. Recombinant expression and properties of the Kunitz-type protease-inhibitor module from the human type VI collagen α3 (VI) chain. Eur. J. Biochem. 225:1994;573-580.
36. Sorokin L. M., Conzelmann S., Ekblom P., Aumailley M., Battaglia C., Timpl R. Monoclonal antibodies against laminin A chain fragment E3 and their effects on cell- and heparin-binding, and on kidney development. Exp. Cell Res. 201:1992;137-144.
37. Engel J. Structure and Function of Laminin. 1993;Academic Press, London.
38. Paulsson M., Aumailley M., Deutzmann R., Timpl R., Beck K., Engel J. Laminin-nidogen complex: extraction with chelating agents and structural characterization. Eur. J. Biochem. 166:1987;11-19.
39. Lindblom A., Engel J., Paulsson M. Characterization of native laminin from bovine kidney and comparisons with other laminin variants. Eur. J. Biochem. 219:1994;383-392.
40. Maniatis, T. Frisch, E. F. Sambrook, J. 1982, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
41. Ekblom M., Klein G., Mugrauer G., Fecker L., Deutzmann R., Timpl R., Ekblom P. Transient and locally restricted expression of laminin A chain mRNA by developing epithelial cells during kidney organogenesis. Cell. 60:1990;337-346.
42. Weller A., Beck S., Ekblom P. Amino acid sequence of mouse tenascin and differential expression of two tenascin isoforms during embryogenesis. J. Cell Biol. 112:1991;355-362.
43. Rosen G. D., Sanes J. R., LaChance R., Cunningham J. M., Roman J., Dean D. C. Roles for the integrin VLA-4 and its counter receptor VCAM-1 in myogenesis. Cell. 69:1992;1107-1119.
44. West W. T., Murphy E. D. Histopathology of heredity, progressive muscular dystrophy in inbred strain 129 mice. Anat. Rec. 137:1960;279-295.
45. Koopman G., Parmentier H. K., Schuurman H. J., Newman W., Meijer C. J., Pals S. T. Adhesion of human B cells to follicular dendritic cells involves both the lymphocyte function-associated antigen 1/intercellular adhesion molecule 1 and very late antigen 4/vascular cell adhesion molecule 1 pathways. J. Exp. Med. 173:1991;1297-1304.
46. Groves R. W., Ross E. L., Barker J. N., MacDonald D. M. Vascular cell adhesion molecule-1: Expression in normal and diseased skin and regulation in vivo by interferon gamma. J. Am. Acad. Dermatol. 29:1993;67-72.
47. Reggiani C., Brocks L., Wirtz P., Loermans H., te Kronnie G. Myosin isoforms in hindlimb muscles of normal and dystrophic (ReJ129 dy/dy) mice. Muscle Nerve. 15:1992;199-208.
48. Frieser M., Hallmann R., Johansson S., Vestweber D., Goodman S. L., Sorokin L. Mouse polymorphonuclear granulocyte binding to extracellular matrix molecules involves beta 1 integrins. Eur. J. Immunol. 26:1996;3127-3136.
49. Gullberg D., Velling T., Sjoberg G., Salmivirta K., Gaggero G., Tiger C. F., Edstrom L., Sejersen T. Tenascin-C expression correlates with macrophage invasion in Duchenne muscular dystrophy and in myositis. Neuromuscul. Disord. 7:1997;39-54.
50. Patton B. L., Miner J. H., Chiu A. Y., Sanes J. R. Distribution and function of laminin in the neuromuscular system of the developing adult and mutant mice. J. Cell Biol. 139:1997;1507-1523.
51. Tiger C. F., Gullberg D. Absence of laminin alpha 1 chain in the skeletal muscle of dystrophic dy/dy mice. Muscle Nerve. 20:1997;1515-1524.
52. Herrmann R., Straub V., Meyer K., Kahn T., Wagner M., Voit T. Congenital muscular dystrophy with laminin alpha 2 chain deficiency: Identification of a new intermediate phenotype and correlation of clinical findings to muscle immunohistochemistry. Eur. J. Pediatr. 155:1996;968-976.
53. Ekblom P. Receptors for laminins during epithelial morphogenesis. Curr. Opin. Cell Biol. 8:1996;700-706.
54. Abrahamson D. R., Irwin M. H., St J. P., Perry E. W., Accavitti M. A., Heck L. W., Couchman J. R. Selective immunoreactivities of kidney basement membranes to monoclonal antibodies against laminin: Localization of the end of the long arm and the short arms to discrete microdomains. J. Cell Biol. 109:1989;3477-3491.
55. Partridge T. Pathophysiology of muscular dystrophy. Br. J. Hosp. Med. 49:1993;26-36.
56. McGeachie J. K., Grounds M. D., Partridge T. A., Morgan J. E. Age-related changes in replication of myogenic cells in mdx mice: quantitative autoradiographic studies. J. Neurol. Sci. 119:1993;169-179.
57. Stirling C. A. Abnormalities in Schwann cell sheaths in spinal nerve roots of dystrophic mice. J. Anat. 119:1975;169-180.
58. Ontell M. P., Hughes D., Hauschka S. D., Ontell M. Transient neonatal denervation alters the proliferative capacity of myosatellite cells in dystrophic (129ReJ dy/dy) muscle. J. Neurobiol. 23:1992;407-419.
59. Bourke D. B., Ontell M. Modification of the phenotypic expression of murine dystrophy: A morphological study. Anat. Rec. 214:1986;17-24.
60. Carlson B. M. Factors influencing the repair and adaption of muscles in aged individuals: satellite cells and innervation. J. Gerontol. 50A:1995;96-100.
61. Durbeej M., Fecker L., Hjalt T., Zhang H. Y., Salmivirta K., Klein G., Timpl R., Sorokin L., Ebendal T., Ekblom P. Expression of laminin alpha 1, alpha 5 and beta 2 chains during embryogenesis of the kidney and vasculature. Matrix Biol. 15:1996;397-413.
62. Aufderheide E., Ekblom P. Tenascin during gut development: Appearance in the mesenchyme, shift in molecular forms, and dependence on epithelial-mesenchymal interactions. J. Cell Biol. 107:1988;2341-2349.
63. Ge A. Z., Butcher E. C. Cloning and expression of a cDNA encoding mouse endoglin, and endothelial cell TGF-beta ligand. Gene. 138:1994;201-206.
64. Takei F. Inhibition of mixed lymphocyte response by a rat monoclonal antibody to a novel murine lymphocyte activation antigen (MALA-2). J. Immunol. 134:1985;1403-1407.
65. Holzmann B., McIntyre B. W., Weissman I. L. Identification of a murine Peyer's patch - specific lymphocyte homing receptor as an integrin molecule with an alpha chain homologous to human VLA-4 alpha. Cell. 56:1989;37-46.